2024-10-24 - Analysis Report
## Thermo Fisher Scientific Inc. (TMO) Stock Analysis Report

**Company Overview:** Thermo Fisher Scientific Inc. is a leading provider of scientific instruments, reagents, and consumables, serving various research, industrial, and healthcare markets.

**1. Performance & Valuation:**

* **Cumulative Return:** TMO has generated a cumulative return of 237.37%, significantly outperforming the S&P 500 (VOO) which returned 136.39%. 
* **Outperformance:**  TMO's outperformance against the S&P 500 is evident with a current relative outperformance of 100.98, placing it within the top 46.82% of its historical performance range. This indicates that TMO has historically outperformed the market and continues to do so currently.

**2. Recent Price Action:**

* **Closing Price:** $590.44
* **5-Day Moving Average:** $595.66 
* **20-Day Moving Average:** $602.31
* **60-Day Moving Average:** $607.02

The stock is currently trading below its 5, 20, and 60-day moving averages, suggesting a potential downward trend in the short-term.

**3. Technical Indicators:**

* **RSI:** 34.98 - This indicates that the stock is currently oversold and may be ripe for a bounce back. 
* **PPO:** -0.15 - A negative PPO suggests that the stock's momentum is decreasing and the downward pressure may continue in the short-term.
* **Delta_Previous_Relative_Divergence:** -6.95 - This indicates a recent (20-day) downward trend in the stock's relative outperformance. 
* **Expected Return:** 36.7% -  This suggests that TMO is expected to generate a significantly higher return than the S&P 500 over a long-term investment horizon (2 years or more).

**4. Recent Earnings & Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-08-02 | 4.05 | $10.54 B |
| 2024-05-03 | 3.47 | $10.35 B |
| 2023-11-03 | 4.44 | $10.57 B |
| 2023-08-04 | 3.53 | $10.69 B |
| 2024-08-02 | 3.53 | $10.69 B |

The most recent earnings report for Q2 2024 showed EPS of $4.05, slightly exceeding analyst expectations of $4.00. Revenue came in at $10.54B, aligning with analyst estimates.  The company's performance reflects continued growth and profitability, signaling its resilience in the market. 

**5. News & Recent Issues:**

* **Market Outlook:** Despite the recent downward trend in the stock, analysts remain optimistic about TMO's long-term growth prospects, driven by the company's strong market position and its continued focus on innovation and product development. 
* **Analyst Opinions:**  Many analysts have issued buy or hold ratings for TMO, citing its strong fundamentals and robust market position. 
* **Performance Highlights:** The company has consistently delivered strong financial performance, exceeding earnings estimates and demonstrating consistent growth.

**6. Overall Analysis:**

TMO presents an interesting investment opportunity. While the recent price action indicates potential short-term weakness, the stock is displaying strong long-term potential.  The technical indicators suggest an oversold condition, indicating a possible rebound in the near future.  Furthermore, the company's consistent earnings performance and optimistic analyst opinions suggest strong growth prospects. Investors seeking long-term exposure to the scientific instruments and consumables industry may find TMO a valuable addition to their portfolios.

**7. Disclaimer:** 
This information is for informational purposes only and should not be considered investment advice. 
